Preliminary financial outlook for 2011
15-11-10 kl. 15/11 2010 08:26 | Exiqon 17,80 (0,00%)
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced its preliminary
financial outlook for 2011. The preliminary outlook does not include any
potential one-time payments from new license agreements or otherwise:
Revenues: DKK 105-115 million
EBITDA: DKK 0.00
This preliminary outlook for 2011 is based on an average USD/DKK exchange rate
of DKK 5.25.
Commenting on the company's preliminary 2011 outlook, CEO, Lars Kongsbak said:
“We expect continued high organic growth in the sale of miRNA research products
next year, and projections are less uncertain than previously for the emerging
market of miRNAs. However, to achieve break-even as planned for 2011 based on
EBITDA, we shall need to continuously focus on costs. Capital resources are
meager and our strategy is therefore to cost-effectively leverage prior years'
investments to broaden our product offering to include other applications and
thereby address new and bigger markets.”
Additional information:
Lars Kongsbak, President and CEO, tel. +45 4566 0888 (cell: +45 4090 2101)
Hans Henrik Chrois Christensen, CFO, tel. +45 4566 0888 (cell: +45 4090 2131)
See the full announcement in the attached PDF or at
www.exiqon.com/investor/portal
Skriv en kommentarer til denne artikel:
Send kommentar

Se flere nyheder om Exiqon
announcement_21_2010_preliminaryoutlook.pdf 



